Skip to main content

Day: October 8, 2024

Global Uranium Files Preliminary Base Shelf Prospectus

VANCOUVER, British Columbia, Oct. 08, 2024 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN) (the “Company”) is pleased to announce that it has filed a preliminary short form base shelf prospectus (the “Preliminary Shelf Prospectus”) with securities regulators in the provinces of Alberta, British Columbia and Ontario (the “Securities Regulators”). A copy of the Preliminary Shelf Prospectus may be obtained under the Company’s SEDAR+ profile at www.sedarplus.ca. The Company also announces that in connection with the filing of the Preliminary Shelf Prospectus, it has filed auditor-reviewed amended and restated unaudited interim condensed consolidated financial statements and the associated MD&A for the six months ended July 31, 2024 (“Reviewed Interim Financial Statements). A Copy of the Reviewed Interim Financial Statements...

Continue reading

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism

Company announcement – No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinismU.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for dasiglucagon in CHI for up to three weeks of dosing due to the timing of a third-party manufacturing facility reinspection The reinspection of the facility was completed in August/September 2024 for which a new inspection classification is pending Zealand remains committed to working with the FDA and the third-party manufacturer to bring dasiglucagon to patients in the U.S. as soon as possibleCopenhagen, Denmark, October 9, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the U.S. Food and...

Continue reading

In Preparation for Hurricane Milton Landfall, Verizon Offers Relief to Impacted Customers

Call/Text/Data usage incurred by customers in Florida’s hardest hit counties will be waived from Oct. 9th-Oct. 23rd What you need to know:Verizon to waive domestic call, text, and data usage for postpaid consumer and Verizon Small Business customers most impacted by the storm in parts of Florida from Oct.9th-Oct. 23rd, 2024.ALPHARETTA, Ga., Oct. 08, 2024 (GLOBE NEWSWIRE) — In response to Hurricane Milton’s forecasted impact on Florida, Verizon is providing an initial relief offer to help affected customers. From Oct. 9th to Oct. 23rd, Verizon will waive domestic call, text, and data usage for postpaid consumer and Verizon Small Business customers* in the following Florida counties: Alachua, Brevard, Charlotte, Citrus, Clay, DeSoto, Flagler, Gilchrist, Glades, Hardee, Hernando, Highlands, Hillsborough, Indian River, Lake, Lee,...

Continue reading

Pricing of CNH Industrial Capital Canada Ltd. Cdn$300 million notes

Basildon, October 8, 2024 CNH Industrial N.V. (NYSE: CNH) today announced that its indirect wholly owned subsidiary, CNH Industrial Capital Canada Ltd., has priced Cdn$300 million in aggregate principal amount of 4.00% notes due April 11, 2028, with an issue price of 99.964%. The notes are being offered on a private placement basis to certain accredited investors in each of the provinces of Canada, which offering is expected to close on October 10, 2024, subject to the satisfaction of customary closing conditions. CNH Industrial Capital Canada Ltd. intends to add the net proceeds from the offering to its general funds and use them for working capital and other general corporate purposes, including, among other things, the purchase of receivables or other assets in the ordinary course of business, as well as the repayment of indebtedness...

Continue reading

NOVONIX and ICoNiChem Enter into Collaboration Agreement Focused on Sustainable Cathode Material Feedstock

BRISBANE, Australia, Oct. 09, 2024 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”), a leading battery materials and technology company, and ICoNiChem Widnes Limited (“ICoNiChem”), a world leader in the production and commercialization of cobalt and nickel salts based in the UK, have announced the signing of a Joint Collaboration Agreement focused on the development of nickel-based cathode active materials (“CAM”). NOVONIX and ICoNiChem have been selected for funding under the 2024 Canada-UK critical minerals call for proposals, which is focused on advancing projects related to critical minerals essential for industries like renewable energy, electric vehicles, and electronics. To support their participation in the project, NOVONIX Battery Technology Solutions Inc., a Canadian division of...

Continue reading

Canoe EIT Income Fund Announces 2024 Voluntary Cash Redemption

CALGARY, Alberta, Oct. 08, 2024 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (“Canoe” or the “Fund”)(TSX – EIT.UN) today announced the 2024 voluntary cash redemption. Voluntary Annual Cash Redemption The redemption date for the Fund’s annual voluntary cash redemption will be December 6, 2024. Unitholders are entitled to redeem units of the Fund at a price equal to 95% of the Average Net Asset Value (NAV) of the three trading days preceding the December 6, 2024 redemption date, less direct costs. Direct costs are expected to be less than 1%. If all redemption requests exceed 10% of the aggregate outstanding units of the Fund on November 15, 2024, the final day to submit units for redemption, the Fund will process redemptions to this maximum on a pro-rata basis based on the total number of units tendered. Payment for units that...

Continue reading

ThreeD Capital Inc. Announces New Investor Relations Agreement

TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce today that it has entered into an agreement (the “Agreement”) with PHK Investments LLC (“PHK”) to provide investor relations services to the Company. Pursuant to the Agreement, the Company will pay a fixed monthly fee of £6,875 (approximately $9,356 CAD) (the “Monthly Fee”) and up to £20,000 (approximately $27,218 CAD) in monthly ad spend which includes the use of third-party social media influencers and web-based platforms, if requested by the Company. Additionally, the Company will issue 100,000 stock options exercisable into common...

Continue reading

Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024

SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2024, after the close of the stock market on Wednesday, October 30, 2024. Merit will hold its investor conference call on the same day (Wednesday, October 30, 2024) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at merit.com. ABOUT MERIT Founded in...

Continue reading

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,000 additional doses of NARCAN® Nasal Spray to be donated to organizations in needGAITHERSBURG, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) remains committed to supporting widespread opioid emergency preparedness by expanding access to NARCAN® Nasal Spray and educating the public on how to respond to an opioid overdose. As opioid overdose fatalities have risen in the workplace in recent years,1 Emergent is working with businesses to prepare for accidental opioid emergencies by ensuring workplaces, facilities, and hospitality venues, among...

Continue reading

Colliers adds leading Australian engineering firm

Acquisition expands infrastructure capabilities across Australia TORONTO and SYDNEY, Oct. 08, 2024 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today that Colliers Engineering & Design Australia (“Colliers Engineering”) has acquired TTM Group Pty Limited (“TTM”), a leading transportation engineering consultancy headquartered in Brisbane, Queensland. The addition will augment Colliers Engineering’s overall scale and add new traffic and transportation capabilities across Queensland, New South Wales, and Victoria. TTM’s senior leadership team will become shareholders in the Colliers Engineering platform under Colliers’ unique partnership model. The business will rebrand as “Colliers Engineering & Design” and fully integrate into the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.